Over 3,700 babies were born with syphilis in 2022, 32% more than in 2021 and 10 times more than in 2012, the Centers for Disease Control and Prevention reported Nov. 7.
Maternal and Child Health News
Latest
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug Administration reminded health care providers recently.
The three-part Beyond Birth podcast series explores how hospitals and health systems can support the social and emotional needs of pregnant people and new parents.
The Centers for Disease Control and Prevention Oct. 23 released interim guidance for clinicians with limited access to the monoclonal antibody nirsevimab, recently approved to prevent respiratory syncytial virus in children aged 2 and under.
San Francisco-based Tia launched in 2017 with a vision of reimagining health care with women at the center and helping them to make better decisions about their health. Now, in its first “Women’s Primary Care ‘Plus’ Outcomes Report,” the company shares data about the impact the company is having on its members.
The American Heart Association has released a free two-hour accredited learning module on maternal cardiovascular risks and disparities to help clinicians address the leading cause of maternal mortality and improve outcomes for pregnant and recently pregnant individuals in their care.
“A recent article in the Wall Street Journal wants you to believe that many of our nation’s emergency departments are incapable of caring for children,” writes Chris DeRienzo, M.D., AHA senior vice president and chief physician executive.
The director and nurse manager for pediatric emergency mental health services at UMass Memorial Health in Massachusetts share how the health system is helping kids receive treatment that fits their needs.
The Centers for Disease Control and Prevention Sept. 22 recommended the first maternal vaccine to protect newborns from severe illness from respiratory syncytial virus, the leading cause of hospitalization for U.S. infants.
The Senate Health, Education, Labor and Pensions Committee today voted 14-7 to advance as amended to the full Senate the Bipartisan Primary Care and Health Workforce Expansion Act (S. 2840), legislation that would cut hospitals and health systems to fund community health centers and health care workforce initiatives.
The U.S. infant mortality rate was essentially unchanged in 2021, but the number of deaths rose 2% to 19,928, the Centers for Disease Control and Prevention reported Sept. 12
Based on an AHA-led discussion with hospital leaders, this resource shares strategies to foster equitable practices in maternal care at the patient and organizational level.
A new report from the National Academies of Sciences, Engineering, and Medicine recommends actions to improve access to pediatric subspecialty care
The Centers for Disease Control and Prevention Sept. 5 alerted clinicians to a recent increase in respiratory syncytial virus in the Southeastern U.S., which could signal the beginning of 2023-2024 RSV season nationally.
The Centers for Medicare & Medicaid Services sent to each state letters regarding compliance with federal requirements related to automatic eligibility renewals, known as “ex parte” renewals, under Medicaid and the Children’s Health Insurance Program.
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease and severe LRTD caused by respiratory syncytial virus in infants from birth through six months of age.
A new report by the Centers for Disease Control and Prevention says 20% of women reported experiences of mistreatment during pregnancy and delivery care, with CDC saying the highest rates reported by Black, Hispanic and multiracial women.
Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings from a federally funded study published in Vaccine.
U.S. hospital emergency departments have improved many aspects of pediatric readiness since 2013, based on responses by over 3,600 EDs to a 2021 assessment by the National Pediatric Readiness Project, JAMA Network Open reports
The Food and Drug Administration approved the first pill to treat postpartum depression in adults, whose symptoms can range from sadness and loss of energy to cognitive impairment and suicidal ideation. Patients would take the drug (Zurzuvae) for 14 days.